Down’s Syndrome Screening in the First Trimester with Additional Serum Markers: Indian Parameters (original) (raw)

Maternal serum screening for Down's syndrome in the first trimester of pregnancy

Ettore Cariati

BJOG: An International Journal of Obstetrics and Gynaecology, 1995

View PDFchevron_right

First trimester screening for Down's syndrome using maternal serum PAPP-A and free beta=hCG in combination with fetal nuchal translucency thickness

Ermanno Vanzi

BJOG: An International Journal of Obstetrics and Gynaecology, 1998

View PDFchevron_right

First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free β-hCG and pregnancy-associated plasma protein-A assays

Kevin Spencer

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005

View PDFchevron_right

Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy

James Densem

BJOG: An International Journal of Obstetrics and Gynaecology, 1996

View PDFchevron_right

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study

Isabelle Czerkiewicz

American Journal of Obstetrics and Gynecology, 2013

View PDFchevron_right

Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories

Peter Benn

Clinical chemistry, 2006

View PDFchevron_right

Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight

James Densem

BJOG: An International Journal of Obstetrics and Gynaecology, 1992

View PDFchevron_right

Maternal serum screening for Down's syndrome in early pregnancy

James Densem

BMJ, 1988

View PDFchevron_right

Second Trimester Antenatal Screening for Down’s Syndrome

Guido Vranken

View PDFchevron_right

A prospective two years study of first trimester screening for Down syndrome

A. Daniilidis

Hippokratia, 2008

View PDFchevron_right

Evaluation of First Trimester Contingent Test for Down ’ S Syndrome Screening

Kusagradhi Ghosh

Journal of Evolution of medical and Dental Sciences, 2015

View PDFchevron_right

Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland

A. Perheentupa, Markku Ryynänen

European Journal of Human Genetics, 2001

View PDFchevron_right

Review article Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions

Peter Benn

2002

View PDFchevron_right

Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome

Nan Okun

Prenatal Diagnosis, 2010

View PDFchevron_right

Performance and Predictive Value of First Trimester Screening Markers for Down Syndrome in Iranian Pregnancies

Mostafa Akbariqomi

Journal of Family & Reproductive Health, 2018

View PDFchevron_right

Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions

Peter Benn

2002

View PDFchevron_right

Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access(R) platform: suitability for use in first trimester Down's syndrome screening

Geralyn Messerlian

Journal of Medical Screening, 2010

View PDFchevron_right

Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing

Peter Benn

Clinica Chimica Acta, 2002

View PDFchevron_right

What are the predominant parameters for Down syndrome risk estimation in first-trimester screening: a data mining study

Ihsan Yozgat

Türk biyokimya dergisi, 2022

View PDFchevron_right

First trimester screening for Down syndrome using free β hCG, total hCG and PAPP-A: an exploratory study

Kevin Spencer

Prenatal Diagnosis, 2007

View PDFchevron_right

Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population

L. Bidat, Isabele Durand-zaleski

American Journal of Obstetrics and Gynecology, 2006

View PDFchevron_right

Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening

Geralyn Messerlian

Journal of Medical Screening, 2012

View PDFchevron_right

Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy

Tri Nguyen

Clinica Chimica Acta, 1996

View PDFchevron_right

Maternal serum markers in screening for Down syndrome

Ann Tabor

Clinical Genetics, 2008

View PDFchevron_right

Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region

David Howe

BMJ, 2002

View PDFchevron_right

Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland

Yrtti Valinen

American Journal of Obstetrics and Gynecology, 2007

View PDFchevron_right

Risk prediction for Down?s syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis

Hsiao-lin Hwa

Journal of Evaluation in Clinical Practice, 2007

View PDFchevron_right

Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies Commentary: Results may not be widely applicable Authors' response

Stuart Logan

BMJ, 2001

View PDFchevron_right

The Effect of Fetal Gender on the Markers of First Trimester Down Syndrome Screening

ekrem Tok

2006

View PDFchevron_right

P07.01: Patient's perception of first trimester risk assessment for Down syndrome: what is a “high risk” for you?

Noirin Russell

Ultrasound in Obstetrics & Gynecology

View PDFchevron_right

The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome

John Owen

American Journal of Obstetrics and Gynecology, 1994

View PDFchevron_right

Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women

Karin Sundberg

Ultrasound in Obstetrics and Gynecology, 2005

View PDFchevron_right

Maternal serum screening for Down's syndrome on population basis

Ulf-Håkan Stenman

Acta Obstetricia et Gynecologica Scandinavica, 1997

View PDFchevron_right

Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures

Geralyn Messerlian

Prenatal Diagnosis, 2015

View PDFchevron_right

Down syndrome screening marker levels in women with a previous aneuploidy pregnancy

Kevin Spencer

Prenatal Diagnosis, 2005

View PDFchevron_right